The blood urea nitrogen-to-albumin ratio (BAR) is used to assess renal function in chronic kidney disease patients, and the albumin-bilirubin (ALBI) score, a recently developed highly responsive model for predicting end-stage liver disease, is another practical instance [2]. This evidence concerns the gene ALB and liver disorder.